A new guideline provided recommendations on benzodiazepine tapering when risks outweigh benefits. Tapering strategy should be adjusted to each patient based on their response, guideline authors said.
MedPage Today on MSN
FDA wants drug pulled from market, citing liver risk. Company says no.
Agency raised questions about avacopan's pivotal trial data and concerns of hepatotoxicity ...
We recently asked the bpHope community to fill out a short questionnaire about their experiences with antidepressants. The results offer a revealing glimpse into the challenges many of you face. In ...
Correspondence to Dr Varun Dhir, Internal Medicine (Rheumatology Unit), Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India; varundhir{at}gmail.com We read with great ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results